Products for Research Use Only
RegisterLogin

BNTA

CAT: 0804-HY-136651-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-136651-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BNTA, a potent extracellular matrix (ECM) modulator, facilitates cartilage structural molecule synthesis on chondrocytes by activating superoxide dismutase 3 (SOD3) . BNTA shows a promising potential for osteoarthritis alleviation by modulating cartilage generation[1].
CAS Number
685119-25-9
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bnta.html
Purity
99.68
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=C(Br)SC=C1S(=O)(C2=CC=CC=C2)=O)C3=CC=CC=C3Cl
Molecular Formula
C17H11BrClNO3S2
Molecular Weight
456.76
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Shi Y, et, al. A small molecule promotes cartilage extracellular matrix generation and inhibits osteoarthritis development. Nat Commun. 2019 Apr 23; 10 (1) : 1914.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-169867BNTX
HY-101307-01BNTX (maleate)

Alternative Products

CatalogName
KCB11925-01Bnta
AR-B07479-01BNTA-d4
AR-B07484-01BNTA Impurity 5
AR-B07480-01BNTA Impurity 1
AR-B07485-01BNTA Impurity 6
AR-B07482-01BNTA Impurity 3
AR-B07486-01BNTA Impurity 7
AR-B07483-01BNTA Impurity 4
AR-B07481-01BNTA Impurity 2
JN888010-01InVivoMAb Anti-Clostridium botulinum botA/BoNT Antibody (BNTA-9.1)

Popular Products